Literature DB >> 25697568

Inducible RNAi system and its application in novel therapeutics.

Yi Liao1, Liling Tang1.   

Abstract

RNA interference (RNAi) was discovered as a cellular defense mechanism more than decade ago. It has been exploited as a powerful tool for genetic manipulation. Characterized with specifically silencing target gene expression, it has great potential application for disease treatment. Currently, there are human clinical trials in progress or planned. Despite the excitement regarding this prominent technology, there are many obstacles and concerns that prevent RNAi from being widely used in the therapeutic field. Among them, the non-spatial and non-temporal control is the most difficult challenge, as well as off-target effects and triggering type I immune responses. Inducible RNAi technology can effectively regulate target genes by inducer-mediated small hairpin RNA expression. Combination with inducible regulation systems this makes RNAi technology more sophisticated and may provide a wider application field. This review discusses approaches of inducible RNAi systems, the potential problem areas and solutions and their therapeutic applications. Given the limitations discussed herein being resolved, we believe that inducible RNAi will be a major therapeutic modality within the next several years.

Entities:  

Keywords:  Applications; RNAi; inducible RNAi systems; lncRNAs; shRNA; therapeutics

Mesh:

Substances:

Year:  2015        PMID: 25697568     DOI: 10.3109/07388551.2014.1003030

Source DB:  PubMed          Journal:  Crit Rev Biotechnol        ISSN: 0738-8551            Impact factor:   8.429


  7 in total

1.  Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment.

Authors:  Marta H Kubala; Yves A DeClerck
Journal:  J Vis Exp       Date:  2017-11-23       Impact factor: 1.355

Review 2.  Long Non-Coding RNAs in Retinal Ganglion Cell Apoptosis.

Authors:  Ningzhi Zhang; Wenye Cao; Xuejun He; Yiqiao Xing; Ning Yang
Journal:  Cell Mol Neurobiol       Date:  2022-02-28       Impact factor: 5.046

3.  Construction of a novel vector expressing Survivin-shRNA and fusion suicide gene yCDglyTK and its application in inhibiting proliferation and migration of colon cancer cells.

Authors:  Ling Ye; Yuan Yang; Xin-Yu Ma; Dan Li; Mei-Li Xu; Pan Tan; Li-Min Long; Hai-Qin Wang; Ting Liu; Yong-Hong Guo
Journal:  Exp Ther Med       Date:  2017-09-20       Impact factor: 2.447

Review 4.  Gene therapy to enhance angiogenesis in chronic wounds.

Authors:  Elnaz Shaabani; Maryam Sharifiaghdam; Reza Faridi-Majidi; Stefaan C De Smedt; Kevin Braeckmans; Juan C Fraire
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-17       Impact factor: 10.183

Review 5.  Genetic engineering of baculovirus-insect cell system to improve protein production.

Authors:  Minqing Hong; Tingting Li; Wenhui Xue; Sibo Zhang; Lingyan Cui; Hong Wang; Yuyun Zhang; Lizhi Zhou; Ying Gu; Ningshao Xia; Shaowei Li
Journal:  Front Bioeng Biotechnol       Date:  2022-09-20

6.  CrxRdy Cat: A Large Animal Model for CRX-Associated Leber Congenital Amaurosis.

Authors:  Laurence M Occelli; Nicholas M Tran; Kristina Narfström; Shiming Chen; Simon M Petersen-Jones
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-07-01       Impact factor: 4.799

Review 7.  Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers.

Authors:  Shi-Jia Jin; Ming-Zhu Jin; Bai-Rong Xia; Wei-Lin Jin
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.